NOVO INTEGRATED SCIENCES by Novo Integrated Sciences, Inc. Financials - Benzinga

NOVO INTEGRATED SCIENCES by Novo Integrated Sciences, Inc.

NVOSOTCEM

Trade with Public

Trade with Public

$0.00390

-0.15-97.38%

Last update: Sep 21, 10:47 AM

Overview News Earnings ForecastFinancialsSentiment Ownership Compare

NOVO INTEGRATED SCIENCES by Novo Integrated Sciences, Inc. Financials

NOVO INTEGRATED SCIENCES by Novo Integrated Sciences, Inc. (NVOS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

US Stocks Edge Lower; Applied Materials Earnings Top Views

Avi Kapoor

Dow Surges 250 Points; MongoDB Shares Plummet

Avi Kapoor

Nasdaq Down 1.5%; Gap Shares Spike Higher

Avi Kapoor

US Stocks Mostly Higher; Headline PCE Inflation Matches Estimates

Avi Kapoor

PRO
Novo Integrated Sciences Q2 EPS $(0.16) Up From $(0.59) YoY, Sales $3.17M Up From $2.56M YoY

Novo Integrated Sciences (NASDAQ:NVOS) reported quarterly losses of $(0.16) per share. This is a 72.88 percent increase over losses of $(0.59) per share from the same period last year. The company reported $3.17 million

Benzinga Newsdesk

PRO
Novo Integrated Sciences Q1 2024 EPS $(0.28) Up From $(1.16) YoY, Revenue $3.891M Up From $3.419M YoY

Benzinga Newsdesk